DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ slid 3.51% to $23.40 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 2.15% to 20,948.36 and Dow Jones Industrial Average falling 1.73% to 45,166.64.
The stock's fall snapped a two-day winning streak.
Catalyst Pharmaceuticals Inc. closed 11.96% short of its 52-week high of $26.58, which the company achieved on June 9th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 0.51% to $240.45, Pfizer Inc. $(PFE)$ fell 1.92% to $27.04, and Abbott Laboratories $(ABT)$ fell 0.55% to $103.99.
Trading volume (754,794) remained 484,935 below its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 27, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 27, 2026 17:22 ET (21:22 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments